204 related articles for article (PubMed ID: 26787600)
1. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
2. Genomic determinants of somatic copy number alterations across human cancers.
Zhang Y; Xu H; Frishman D
Hum Mol Genet; 2016 Mar; 25(5):1019-30. PubMed ID: 26732428
[TBL] [Abstract][Full Text] [Related]
3. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis identifies global gene dosage sensitivity in cancer.
Fehrmann RS; Karjalainen JM; Krajewska M; Westra HJ; Maloney D; Simeonov A; Pers TH; Hirschhorn JN; Jansen RC; Schultes EA; van Haagen HH; de Vries EG; te Meerman GJ; Wijmenga C; van Vugt MA; Franke L
Nat Genet; 2015 Feb; 47(2):115-25. PubMed ID: 25581432
[TBL] [Abstract][Full Text] [Related]
5. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
6. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer patterns of somatic copy number alteration.
Zack TI; Schumacher SE; Carter SL; Cherniack AD; Saksena G; Tabak B; Lawrence MS; Zhsng CZ; Wala J; Mermel CH; Sougnez C; Gabriel SB; Hernandez B; Shen H; Laird PW; Getz G; Meyerson M; Beroukhim R
Nat Genet; 2013 Oct; 45(10):1134-40. PubMed ID: 24071852
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
Jones RA; Moorehead RA
Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
[TBL] [Abstract][Full Text] [Related]
13. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
[TBL] [Abstract][Full Text] [Related]
14. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
Wee Y; Wang T; Liu Y; Li X; Zhao M
Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
[TBL] [Abstract][Full Text] [Related]
15. Low-cost and clinically applicable copy number profiling using repeat DNA.
Abujudeh S; Zeki SS; van Lanschot MCJ; Pusung M; Weaver JMJ; Li X; Noorani A; Metz AJ; Bornschein J; Bower L; Miremadi A; Fitzgerald RC; Morrissey ER; Lynch AG
BMC Genomics; 2022 Aug; 23(1):599. PubMed ID: 35978291
[TBL] [Abstract][Full Text] [Related]
16. Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types.
Sivakumar S; San Lucas FA; Jakubek YA; Ozcan Z; Fowler J; Scheet P
Genetics; 2021 Mar; 217(1):1-12. PubMed ID: 33683368
[TBL] [Abstract][Full Text] [Related]
17. Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity.
Pavel AB; Sonkin D; Reddy A
BMC Syst Biol; 2016 Feb; 10():16. PubMed ID: 26864072
[TBL] [Abstract][Full Text] [Related]
18. Recurrent copy number gains drive PKCĪ¹ expression and PKCĪ¹-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.
Li Y; Zhang L; Ball RL; Liang X; Li J; Lin Z; Liang H
Hum Mol Genet; 2012 Nov; 21(22):4957-65. PubMed ID: 22899649
[TBL] [Abstract][Full Text] [Related]
20. labelSeg: segment annotation for tumor copy number alteration profiles.
Zhao H; Baudis M
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38300514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
